Comprehensive analysis of transcriptomics and metabolomics to understand triptolide-induced liver injury in mice

Jie Zhao,Cen Xie,Kanglong Wang,Shogo Takahashi,Kristopher W Krausz,Dasheng Lu,Qiong Wang,Yuhong Luo,Xianqiong Gong,Xiyan Mu,Qiao Wang,Suwen Su,Frank J Gonzalez,Kristopher W. Krausz,Frank J. Gonzalez

DOI: https://doi.org/10.1016/j.toxlet.2020.08.007

IF: 4.271

2020-10-01

Toxicology Letters

Abstract:<p>Triptolide, a major active component of <em>Triptergium wilfordii</em> Hook. f, is used in the treatment of autoimmune disease. However, triptolide is associated with severe adverse reactions, especially hepatotoxicity, which limits its clinical application. To examine the underlying mechanism of triptolide-induced liver injury, a combination of dose- and time-dependent toxic effects, RNA-seq and metabolomics were employed. Triptolide-induced toxicity occurred in a dose- and time-dependent manners and was characterized by apoptosis and not necroptosis. Transcriptomics profiles of the dose-dependent response to triptolide suggested that PI3K/AKT, MAPK, TNFα and p53 signaling pathways were the vital steps in triptolide-induced hepatocyte apoptosis. Metabolomics further revealed that glycerophospholipid, fatty acid, leukotriene, purine and pyrimidine metabolism were the major metabolic alterations after triptolide exposure. Finally, acylcarnitines were identified as potential biomarkers for the early detection of triptolide-induced liver injury.</p>

toxicology

What problem does this paper attempt to address?

The paper aims to explore the mechanisms of liver injury induced by Triptolide. Triptolide is a major active component extracted from Tripterygium wilfordii, used to treat autoimmune diseases, but its severe adverse reactions, especially hepatotoxicity, limit its clinical application. To investigate the specific mechanisms of liver injury caused by Triptolide, researchers conducted dose- and time-dependent toxicological experiments, transcriptomic analysis (RNA-seq), and metabolomic analysis.

The main findings are as follows:
1. **Dose-dependent liver injury**: Triptolide causes varying degrees of liver injury at different doses, manifested as hepatocyte apoptosis rather than necrosis.
2. **Time-dependent liver injury**: Triptolide also causes liver injury at different time points, with significant increases in damage after 24 hours.
3. **Apoptotic effect**: Transcriptomic results show that Triptolide induces hepatocyte apoptosis through the PI3K/AKT, MAPK, TNFα, and p53 signaling pathways.
4. **Metabolic changes**: Metabolomic analysis revealed major changes in glycerophospholipid, fatty acid, leukotriene, purine, and pyrimidine metabolism after Triptolide exposure.
5. **Acylcarnitine as a biomarker**: Acylcarnitine was identified as a potential biomarker for early detection of liver injury induced by Triptolide.

In conclusion, this study comprehensively explores the specific molecular mechanisms and metabolic pathways of liver injury caused by Triptolide through multi-omics analysis techniques.